Headwaters Capital Management Sold Transmedics (TMDX) After a Strong Q1 Report
Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Transmedics Group Inc. (TMDX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Zevenbergen Capital Investments Nancy Zevenbergen | 121,528 | $16,286,019 | 0.32% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $62.00 | 2,500 | $155,000.00 | 13,693 | 2023-08-29 | Filing | |
| $22.71 | 74,062 | $1,681,948.02 | 302,893 | 2021-11-29 | Filing | |
| $22.14 | 25,938 | $574,267.32 | 228,831 | 2021-11-29 | Filing | |
| $17.00 | 10,000 | $170,000.00 | 10,000 | 2019-11-11 | Filing | |
| $16.00 | 33,333 | $533,328.00 | 33,333 | 2019-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $139.80 | 686 | $95,902.80 | 13,955 | 2025-06-09 | Filing | |
| $126.45 | 5,000 | $632,250.00 | 2,866 | 2025-05-27 | Filing | |
| $123.88 | 732 | $90,680.16 | 12,134 | 2025-05-23 | Filing | |
| $115.63 | 6,000 | $693,780.00 | 732 | 2025-05-09 | Filing | |
| $76.43 | 2,407 | $183,967.01 | 36,042 | 2025-03-03 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 21,071 | $2,823,725 | 1.5% | |
| 2. | 19,206 | $2,573,796 | 0.06% | |
| 3. | 12,443 | $1,667,486 | 0.13% | |
| 4. | 12,056 | $1,615,625 | 0.01% | |
| 5. | 11,023 | $1,477,192 | 0% |
News See All
Oppenheimer Raises TransMedics (TMDX) PT to $150 Following Key OrganOx Metra Label Update
TransMedics Group Inc. (NASDAQ:TMDX) is one of the best mid cap growth stocks to invest in now.
11 Best Mid Cap Growth Stocks To Invest In Now
On June 18, Scott Wren, Wells Fargo senior global market strategist, joined CNBC's 'Closing Bell Overtime' to talk about how the market sell-off is an opportunity to step in.
TransMedics (TMDX) Continues to Scale Innovation in Organ Transplant Care
TransMedics Group Inc. (NASDAQ:TMDX) is one of the 10 best growth stocks to buy according to billionaires.
10 Best Growth Stocks to Buy According to Billionaires
Growth stocks are companies that are expected to report above-average earnings and revenue growth.
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.
Piper Sandler Boosts TransMedics (TMDX) PT to $145, Keeps Overweight Rating
On Wednesday, Piper Sandler analyst Matt O’Brien raised the price target on TransMedics Group Inc. (NASDAQ:TMDX) to $145 from $125, while maintaining an Overweight rating on the shares.
11 Unstoppable Growth Stocks to Invest in Now
BlackRock highlighted that the trade conflict between the US and China continues to cause major economic disruptions.
TransMedics Group, Inc. (TMDX): A Bull Case Theory
We came across a bullish thesis on TransMedics Group, Inc. (TMDX) on Substack by Oliver | MMMT Wealth. In this article, we will summarize the bulls’ thesis on TMDX. TransMedics Group, Inc.
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Billionaire Hedge Funds
